Medisim

Noninvasive Thermometry

Health Tech & Life Sciences
Private
Follow

Company Overview

Snapshot

Founded in December 1995 by Moshe Yarden and Ilan Vadai, Medisim operates with 11–50 employees. The company specializes in medical devices and announced in August 2020 that Kopin Corporation selected its Binocular Microdisplay Module for Medisim's BinoVision Head-Mounted Goggles.

Business overview

Medisim develops medical devices focused on enhancing patient health and streamlining caregiver workflows. The company's core products include platforms and therapies addressing unmet needs in home thermometry, core temperature monitoring, and amblyopia therapy, such as its BinoVision video goggles. Medisim operates within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Medical Devices, serving markets that include consumers (parents and children) and healthcare providers and patients.

Strategic signal

In August 2020, Medisim announced that Kopin Corporation selected its Binocular Microdisplay Module and A912 Driver IC for Medisim's BinoVision Head-Mounted Goggles. This partnership is significant as it validates Medisim's technology for amblyopia (lazy eye) treatment, leveraging Kopin's microdisplays to enhance brightness, a critical requirement for the application. This signals strong product development and strategic collaboration, indicating potential for increased market adoption and further innovation in medical products.

Log in to access full profile

Company Intelligence Q&A

What is Medisim's primary focus in medical device development?
Medisim primarily focuses on developing platforms and therapies that address unmet medical needs, with expertise in home thermometry, core temperature monitoring, and amblyopia therapy.
Which product from Medisim was featured in an article about revolutionary eye health advances?
In August 2019, Medisim's BinoVision video goggles were highlighted in an article discussing 12 revolutionary Israeli therapeutic and diagnostic technologies for eye health, specifically for treating amblyopia.
What was the significance of Medisim's participation in MEDICA 2017?
In November 2017, Medisim participated in MEDICA 2017 in Düsseldorf, Germany, as part of a delegation of Israeli medical device and healthcare developers. This showcased the company's emergency medical services specialized products at one of the largest global trade fairs for the medical sector.
What is BinoVision and what was its status in February 2017?
BinoVision is Medisim's video goggle system designed to treat amblyopia (lazy eye) by stimulating the brain to improve visual function. In February 2017, Medisim was working to commercialize BinoVision and had applied for approval by the US FDA for the device, following clinical trials that showed high compliance and improved results in children.
What was the product development announcement involving Medisim and Kopin Corporation?
In August 2020, Kopin Corporation announced that Medisim Ltd. selected its Binocular Microdisplay Module and A912 Driver IC for Medisim's BinoVision Head-Mounted Goggles, which are designed to treat Amblyopia.
Log in to access full profile